Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levothyroxine in Recurrent Pregnancy Loss
NCT06036576Phase 3Completed
- Sponsor
- Al-Kindy College of Medicine
- Start
- Mar 2022
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Al-Kindy College of Medicine. Primary endpoint: Pregnancy Success Rate at 12 weeks. Started Mar 2022; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT06036576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06036576.